BioCryst: Event in offing
Great Panther updates Guanajuato resource
An update from Ticker Trax™:A Stockhouse Exclusive(www.tickertrax.com)
BioCryst Pharmaceuticals (NASDAQ: BCRX) is close to seeing its long-researched peramivir anti-viral inhibitor reach stockpile status for willing governments.
The marking of such status for a non-approved molecular compound likely will come in the United States, Japan or Canada. (Please see archived Ticker Trax June 26, 2009, for details.) The new status for the experimental H1N1 treatment – administered intravenously in hospitals or clinics -- could come in the next several days as health agencies prepare to defend their borders from the highly transmissible, but still mellow in terms of virulence, influenza.
The virulence of the pandemic-labeled Type A influenza will change as H1N1 interacts with an H5N1 virus (commonly referred to as avian flu) that recently was sub-typed in 25 human cases on a single day in Egypt.
The chart shown here, courtesy of Stockstream and Stockhouse, shows shares of NASDAQ-traded BioCryst, our life sciences Planetary Prospect. (We at home have owned shares of the drug discovery company for almost five years and are purchasing more today at $4.06 or so. We have no interest in pursuing vaccine makers as a proxy for influenza treatments but wish all of them the best of luck.)
The Alabama company, of late, has not granted interview requests from Ticker Trax. The shares usually are volatile but are trading now in an early July languor. We expect developments in the influenza story this week and next.
- Great Panther Resources (TSX: T.GPR) on Wednesday published a five million-ounce silver resource on part of its Guanajuato property in Mexico. The Cato Clavo section of the mine is one of three drilling zones that CEO Robert A. Archer is targeting for possible further development. Cato Clavo produces about half of the one million or so ounces of silver that Great Panther’s M
exican team pulls from Guanajuato each year. Grades for the ore in the resource estimate were in the 300-gram range per tonne for silver and more than one gram of gold per tonne. The resource estimate is Great Panther’s first at Guanajuato and is part of Mr. Archer’s strategy of gaining more heft as it pursues further drilling at the Guanajuato property and as the company pursues purchases of other mines in and around Durango and elsewhere in Mexico. I will be visiting Guanajuato for a mine tour of Great Panther and of Endeavour Silver (TSX: T.EDR) July 22-24. Both are Planetary Prospects. The Great Panther press release is a model for all compliant resource estimates – with no buried ‘bad’ news such as busted drills and with a minimum of geology jargon.Please read it.
- To date, we at home own seven of the eight Planetary Prospects. We intend to purchase Endeavour Financial (TSX: T.EDV) shares in the coming week. Please see Endeavour's prospectus filed earlier this year. The company has no relationship to Endeavour Silver.
- On the Instant Value front: Please revisit Ticker Trax from June 10, when we outlined the Instant Value case for the new Encanto Potash Corp. The company is an Endeavour Financial- engineered combination whose shares are trading as ticker AGN.H in Canada. A three-way, tie-in involving iron ore, uranium and potash assets will result in Angus Ventures (TSX: V.AGN.H ) merging with Encanto in the coming week … and a change of ticker symbol in Canada.
- Stockhouse and Ticker Trax soon will be offering an Instant Value service at a quarterly charge. The service is intended to identify fast-moving events and other factors that will add instant value to selected investments. It is intended for those who want fast action in their investments.
That is really all for now. Happy July! Thank you for subscribing.
Ticker Trax™
Subscribers, please click herefor password-secureTicker Trax.
Ticker Trax™ is published by Stockgroup Media Inc. Ticker Trax is an information service for subscribers and neither Stockhouse nor Thom Calandra is a broker or an investment advisor. None of the information contained therein constitutes a recommendation by Mr. Calandra or Stockhouse/Stockgroup Media that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. Ticker Trax does not purport to tell or suggest the investment securities subscribers or readers should buy or sell for themselves. Subscribers and readers of Ticker Trax should conduct their own research and due diligence and obtain professional advice before making any investment decisions. Ticker Trax will not be liable for any loss or damage caused by a reader’s reliance on information obtained in the reports. Subscribers and readers are solely responsible for their own investment decisions. Opinions expressed in Ticker Trax are based on sources believed to be reliable and are written in good faith, but no representation or warranty, expressed or implied, is made as to their accuracy or completeness. All information contained in Ticker Trax should be independently verified. The editor and publisher are not responsible for errors or omissions or responsible for keeping information up to date or for correcting any past information. Ticker Trax does not receive compensation of any kind from any companies that may be mentioned in the report. Any opinions expressed are subject to change without notice. Owners, employees and writers may hold positions in the securities that are discussed in Ticker Trax. PLEASE DO NOT EMAIL THOM SEEKING PERSONALIZED INVESTMENT ADVICE, WHICH HE CANNOT PROVIDE. Copyright 2009 all rights reserved.
Copyright © 2009 Stockhouse Inc. Stockhouse and Ticker Trax are trademarks of Stockhouse Inc.